INVO Bioscience, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
INVO Bioscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • INVO Bioscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.25M, a 0.21% decline year-over-year.
  • INVO Bioscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$7.08M, a 29.9% increase year-over-year.
  • INVO Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.03M, a 26.2% increase from 2022.
  • INVO Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.9M, a 63.7% decline from 2021.
  • INVO Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.65M, a 20.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$7.08M -$2.25M -$4.66K -0.21% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$7.08M -$1.6M +$954K +37.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$8.03M -$1.99M +$772K +27.9% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-17
Q3 2023 -$8.81M -$1.25M +$1.3M +51% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$10.1M -$2.24M +$561K +20% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$10.7M -$2.55M +$223K +8.05% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$10.9M -$2.77M -$2.63M -1855% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-17
Q3 2022 -$8.27M -$2.55M -$307K -13.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$7.96M -$2.8M -$984K -54.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$6.98M -$2.77M -$321K -13.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$6.65M -$142K +$3.67M +96.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$10.3M -$2.24M -$471K -26.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$9.85M -$1.82M -$494K -37.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$9.36M -$2.45M -$1.01M -69.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$8.35M -$3.81M -$3.05M -403% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$5.3M -$1.77M -$1.06M -149% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$4.23M -$1.32M -$1.08M -448% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$3.15M -$1.44M -$986K -215% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.17M -$757K +$14.3K +1.85% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$2.18M -$710K -$415K -141% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$1.77M -$242K +$1.62M +87% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$3.39M -$459K -$314K -217% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$3.08M -$771K -$570K -283% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$2.51M -$295K -$146K -98.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$2.36M -$1.87M -$1.73M -1262% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$632K -$145K +$70.2K +32.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$702K -$201K +$74.9K +27.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$777K -$149K +$62K +29.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$839K -$137K +$1.32M +90.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.16M -$215K -$33.6K -18.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.12M -$276K -$32.3K -13.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$2.09M -$211K -$87.6K -71.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$2M -$1.46M +$2.99M +67.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-09-05
Q1 2016 -$5M -$181K -$36.7K -25.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-09-05
Q4 2015 -$4.96M -$244K +$1.07M +81.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-20
Q3 2015 -$6.03M -$123K -$5.48K -4.65% Jul 1, 2015 Sep 30, 2015 10-Q 2017-09-05
Q2 2015 -$6.02M -$4.45M -$4.26M -2281% Apr 1, 2015 Jun 30, 2015 10-Q 2017-09-05
Q1 2015 -$1.76M -$145K -$27.3K -23.3% Jan 1, 2015 Mar 31, 2015 10-Q 2017-09-05
Q4 2014 -$1.73M -$1.31M -$1.17M -842% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-17
Q3 2014 -$561K -$118K +$96.2K +45% Jul 1, 2014 Sep 30, 2014 10-K 2017-03-17
Q2 2014 -$657K -$187K -$81.9K -78.1% Apr 1, 2014 Jun 30, 2014 10-K 2017-03-17
Q1 2014 -$575K -$117K +$185K +61.2% Jan 1, 2014 Mar 31, 2014 10-K 2017-03-17
Q4 2013 -$761K -$139K -$96.1K -223% Oct 1, 2013 Dec 31, 2013 10-K 2017-03-17
Q3 2013 -$665K -$214K +$26.4K +11% Jul 1, 2013 Sep 30, 2013 10-K 2017-03-17
Q2 2013 -$691K -$105K +$34.4K +24.7% Apr 1, 2013 Jun 30, 2013 10-K 2017-03-17
Q1 2013 -$725K -$303K -$58.9K -24.2% Jan 1, 2013 Mar 31, 2013 10-K 2017-03-17
Q4 2012 -$666K -$43.1K Oct 1, 2012 Dec 31, 2012 10-K 2017-03-17
Q3 2012 -$240K -$141K -142% Jul 1, 2012 Sep 30, 2012 10-K 2017-03-17
Q2 2012 -$139K +$168K +54.6% Apr 1, 2012 Jun 30, 2012 10-K 2017-03-17
Q1 2012 -$244K Jan 1, 2012 Mar 31, 2012 10-K 2017-03-17
Q3 2011 -$99.2K +$136K +57.8% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q2 2011 -$307K +$84.1K +21.5% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-22
Q3 2010 -$235K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$391K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.